Mako Yamamoto Selected Research

Mako Yamamoto Research Topics

19	Neoplasms (Cancer) 01/2024 - 02/2009
5	Pancreatic Neoplasms (Pancreatic Cancer) 04/2015 - 01/2014
5	Neoplasm Metastasis (Metastasis) 01/2015 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2024 - 01/2016
2	Fibrosarcoma 05/2015 - 01/2015
2	Sarcoma (Soft Tissue Sarcoma) 01/2015 - 12/2014
2	Osteosarcoma (Osteogenic Sarcoma) 12/2014 - 09/2014
1	Premature Aging 10/2022
1	Clostridium Infections 01/2021
1	Progeria (Hutchinson Gilford Syndrome) 01/2019
1	Ulcer 01/2018
1	Infections 07/2015
1	Ovarian Neoplasms (Ovarian Cancer) 05/2015
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 11/2014
1	Ischemia 10/2010
1	Brain Ischemia (Cerebral Ischemia) 10/2010
1	Transient Ischemic Attack 10/2010
1	Vascular Remodeling 08/2010

8	Green Fluorescent ProteinsIBA 07/2015 - 01/2014
3	Red Fluorescent ProteinIBA 05/2015 - 09/2014
2	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 10/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 07/2015 - 05/2015
2	Proteins (Proteins, Gene)FDA Link 04/2015 - 10/2014
2	Gemcitabine FDA Link 01/2015 - 12/2014
2	Indicators and Reagents (Reagents)IBA 01/2015 - 01/2014
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 10/2010 - 08/2010
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	InterferonsIBA 01/2024
1	IsoflavonesIBA 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024
1	GenisteinIBA 01/2024
1	HeterochromatinIBA 10/2022
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2015
1	pazopanib FDA Link 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014
1	Bevacizumab (Avastin)FDA Link 12/2014
1	Carrier Proteins (Binding Protein)IBA 10/2014
1	ChromatinIBA 10/2014
1	Conditioned Culture MediaIBA 01/2014
1	Zoledronic Acid (Zometa)FDA Link 01/2014
1	Cytotoxins (Cytolysins)IBA 01/2014
1	Metalloproteases (Metalloproteinases)IBA 05/2012
1	NestinIBA 10/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2010
1	Tissue Inhibitor of MetalloproteinasesIBA 10/2010
1	Laminin (Merosin)IBA 10/2010
1	Peptide Hydrolases (Proteases)FDA Link 02/2009

7	Therapeutics 01/2024 - 01/2014
3	Transplantation 01/2018 - 09/2014
3	Drug Therapy (Chemotherapy) 12/2014 - 01/2014
2	Aftercare (After-Treatment) 01/2015 - 11/2014
1	Fecal Microbiota Transplantation 01/2021
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Intraperitoneal Injections 05/2015
1	Absorbable Gelatin Sponge 01/2014